Scythian Biosciences Corp. announced that Mr. Vic Neufeld and Mr. George Scorsis, are joining the Board of Directors of Scythian effective January 15, 2018. Mr. Neufeld and Mr. Scorsis will also act as members of the company’s Audit and Compensation committees. Mr. Neufeld will act as Chair of the Audit Committee and Mr. Scorsis will act as Chair of the Compensation Committee. Along with their great expertise and backgrounds, Mr. Neufeld and Mr. Scorsis will also bring to Scythian new relationships and allow Scythian to expand its business globally into other cannabis-related activities, while still focusing on its concussions and traumatic brain injury research. Mr. Neufeld is the Chief Executive Officer and Chair of the Board of Aphria Inc. Mr. Scorsis is currently a director and the Chief Executive Officer of Liberty Health Sciences Inc. In connection with these appointments, Mr. Michael Petter and Mr. Peter Benz have resigned as Directors of Scythian and members of the Audit Committee and Compensation Committee January 15, 2018. The company also announced that Ms. Renah Persofsky has joined the Company as an advisory committee member. Ms. Persofsky has a rich history of investing in early stage start-up companies where she helps mentor CEOs in the art of bringing MVP products to market, and growing their business. She serves as Board Chair for mobile on-demand senior care and child care start-up, BookJane, and is a board member for retail/QSR automation software specialty firm MeazureUp Inc. She is presently an executive consultant in the Innovation Group at CIBC. Ms. Persofsky is currently on the board of directors of Aphria Inc.